title: Bactericidal activity of mammalian cathelicidin-derived peptides.
abstract: Endogenous antimicrobial peptides of the cathelicidin family contribute to innate immunity. The emergence of widespread antibiotic resistance in many commonly encountered bacteria requires the search for new bactericidal agents with therapeutic potential. Solid-phase synthesis was employed to prepare linear antimicrobial peptides found in cathelicidins of five mammals: human (FALL39/LL37), rabbit (CAP18), mouse (mCRAMP), rat (rCRAMP), and sheep (SMAP29 and SMAP34). These peptides were tested at ionic strengths of 25 and 175 mM against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus. Each peptide manifested activity against P. aeruginosa irrespective of the NaCl concentration. CAP18 and SMAP29 were the most effective peptides of the group against all test organisms under both low- and high-salt conditions. Select peptides of 15 to 21 residues, modeled on CAP18 (37 residues), retained activity against the gram-negative bacteria and methicillin-sensitive S. aureus, although the bactericidal activity was reduced compared to that of the parent peptide. In accordance with the behavior of the parent molecule, the truncated peptides adopted an alpha-helical structure in the presence of trifluoroethanol or lipopolysaccharide. The relationship between the bactericidal activity and several physiochemical properties of the cathelicidins was examined. The activities of the full-length peptides correlated positively with a predicted gradient of hydrophobicity along the peptide backbone and with net positive charge; they correlated inversely with relative abundance of anionic residues. The salt-resistant, antimicrobial properties of CAP18 and SMAP29 suggest that these peptides or congeneric structures have potential for the treatment of bacterial infections in normal and immunocompromised persons and individuals with cystic fibrosis.
authors.affiliation: Department of Internal Medicine, University of Iowa College of Medicine Iowa City, Iowa 52242, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Travis
authors.forename: N N
authors.initials: NN
authors.lastname: Anderson
authors.forename: W R
authors.initials: WR
authors.lastname: Forsyth
authors.forename: C
authors.initials: C
authors.lastname: Espiritu
authors.forename: B D
authors.initials: BD
authors.lastname: Conway
authors.forename: E P
authors.initials: EP
authors.lastname: Greenberg
authors.forename: P B
authors.initials: PB
authors.lastname: McCray
authors.forename: R I
authors.initials: RI
authors.lastname: Lehrer
authors.forename: M J
authors.initials: MJ
authors.lastname: Welsh
authors.forename: B F
authors.initials: BF
authors.lastname: Tack
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry* / Q000494:pharmacology*; D054804:Cathelicidins; D004926:Escherichia coli / Q000187:drug effects*; D006461:Hemolysis; D006801:Humans; D008163:Luminescent Measurements; D008322:Mammals; D051379:Mice; D011487:Protein Conformation; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D012756:Sheep; D013211:Staphylococcus aureus / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D054804:Cathelicidins